| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/14/2006 | CN1259071C Use of Hubei erectum in preparing anti-depression, anti-anxiety or/and brain improving medicine |
| 06/14/2006 | CN1259062C External use medicine for treating facial paralysis peripherica and its prepn |
| 06/14/2006 | CN1259045C Use of sinapine in preparing medicine for preventing and curing senile dementia |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060834 Using a 2-aminoquinoline compound |
| 06/13/2006 | US7060826 Central nervous system disorders; Alzheimer's disease; huntington's disease; Parkinson's disease; attention deficit disorders; schizophrenia; Tourette's syndrome |
| 06/13/2006 | US7060725 Substituted sulfamate anticonvulsant derivatives |
| 06/13/2006 | US7060716 Compound containing two triple bonds |
| 06/13/2006 | US7060702 Chemical compounds |
| 06/13/2006 | US7060701 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/13/2006 | US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 06/13/2006 | US7060698 5-alkylaminocarbonyl-substituted, e.g., 4-(1-benzyl-piperidin-4-yl)-2-isopropyl-3-oxo-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepine-5-carboxylic acid tert-butylamide; gamma -secretase inhibitors for the treatment of Alzheimer's disease. |
| 06/13/2006 | US7060694 High potency dihydroergotamine compositions |
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060683 for treatment of neurodegeneration, stroke, Alzheimer's, amyotrophy, motor neuron damage, acute central nervous system injury, muscular dystrophy, bone resorption, platelet aggregation, cataracts and inflammation |
| 06/13/2006 | US7060679 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 06/13/2006 | US7060675 Administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes |
| 06/13/2006 | US7060671 Peptides containing N-substituted D-amino acids for preventing β-strand association |
| 06/13/2006 | US7060449 Method of preparing GALR2 receptors composition |
| 06/13/2006 | US7060302 Metal-containing compositions, preparations and uses |
| 06/13/2006 | US7060290 Phosphocholine linked prodrug derivatives |
| 06/13/2006 | US7060269 Anti-VEGF antibodies |
| 06/13/2006 | US7060259 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 06/13/2006 | US7060255 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 06/13/2006 | US7060254 Aerosol; heating thin film on solid support; vaporization with air flow |
| 06/13/2006 | CA2302601C Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience |
| 06/13/2006 | CA2268954C Oxadiazoles, processes for their preparation and their use as medicaments |
| 06/08/2006 | WO2006060762A2 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 06/08/2006 | WO2006060702A1 Substitued 3,4-dihydrothieno [2,3-d] pyrmidines as tissue transglutaminase inhibitors |
| 06/08/2006 | WO2006060082A1 Tricyclic compounds, preparation thereof and use thereof as cholinesterase activity inhibitors |
| 06/08/2006 | WO2006060044A1 Toxin compounds with enhanced membrane translocation characteristics |
| 06/08/2006 | WO2006059959A1 Nogo a protein fragments as neuronal network-interacting peptides |
| 06/08/2006 | WO2006059778A1 Substituted pyridone derivative |
| 06/08/2006 | WO2006059777A1 Remedy for alzheimer’s disease |
| 06/08/2006 | WO2006059744A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 06/08/2006 | WO2006059713A1 Preventive and/or therapeutic agent for drug dependence |
| 06/08/2006 | WO2006059423A1 Medicine for treatment of disease caused by hyperstimulatory cytotoxicity and therapeutic method |
| 06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | WO2006058879A1 Novel diazabicyclic aryl derivatives as cholinergy ligands |
| 06/08/2006 | WO2006058781A2 Finasteride, dutasteride and related compounds for preventing/treating neurologically-associated disorders |
| 06/08/2006 | WO2006058753A1 Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine d3 receptor |
| 06/08/2006 | WO2006058720A2 Novel compounds for the treatment of neurological disorders |
| 06/08/2006 | WO2006058536A1 Method of providing fast relief to a user of a nicotine chewing gum |
| 06/08/2006 | WO2006058487A1 An extractive of piper laetisipicum c.dc., its process and its uses |
| 06/08/2006 | WO2006058427A1 Platelet-derived growth factor-responsive neural precursor cells and progeny thereof |
| 06/08/2006 | WO2006044958A8 Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 06/08/2006 | WO2006044504A8 Cgrp receptor antagonists |
| 06/08/2006 | WO2006042440A8 Pharmaceutical canscora diffusa-containing composition |
| 06/08/2006 | WO2006040451A3 Novel 9h-pyrido[2,3-b]indole derivatives serving as cdk and gsk3 inhibitors, method for the preparation thereof, and the pharmaceutical compositions containing such compounds |
| 06/08/2006 | WO2006034465A8 Memantine for the treatment of childhood behavioral disorders |
| 06/08/2006 | WO2006027691A3 Methods of treating mood disorders using benzisoxazole containing diazabicyclic compounds |
| 06/08/2006 | WO2006027474A3 Novel imidazopyridine derivatives having an affinity with respect to melatonin receptors, method for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 06/08/2006 | WO2006026533A3 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors |
| 06/08/2006 | WO2006021656A3 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 06/08/2006 | WO2006016828A3 Use of alpha ketoglutarate for treating alzheimer, parkinson |
| 06/08/2006 | WO2006012476A3 Method for treating nervous system disorders and conditions |
| 06/08/2006 | WO2006010620A3 Olanzapine salts and their conversion to olanzapine free base |
| 06/08/2006 | WO2006000903A3 Use of reboxetine for the treatment of pain |
| 06/08/2006 | WO2005099671A3 Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 06/08/2006 | WO2004073653A3 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 06/08/2006 | US20060122411 Chloride channel opener |
| 06/08/2006 | US20060122397 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor; neurological disorders, psychiatric disorders, acute and chronic pain |
| 06/08/2006 | US20060122392 Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 06/08/2006 | US20060122280 Muscarinic agonists |
| 06/08/2006 | US20060122271 Stable gabapentin having pH within a controlled range |
| 06/08/2006 | US20060122270 Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism |
| 06/08/2006 | US20060122249 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 06/08/2006 | US20060122244 Hypoglycemic agents; antidiabetic agentys; side effect reduction; cardiovascular disorders; anticancer agents |
| 06/08/2006 | US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 06/08/2006 | US20060122235 Amine oxidase inhibitor; use in treating Alzheimer's disease; for example, (RS)-1-[6-(4-fluoro-benzyloxy)-pyridin-3-yl]-5-oxo-pyrrolidine-3-carboxylic acid methylamide |
| 06/08/2006 | US20060122234 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/08/2006 | US20060122229 4,5-diarylthiazole derivatives as cb-1 ligands |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122219 Use of flumazenil in the production of a medicament for the treatment of cocaine dependency |
| 06/08/2006 | US20060122218 e.g. (2R,3S)-2-(2,3-Dichlorophenoxymethyl)-8-methyl-3-(2-thienyl-8-aza-bicyclo[3.2.1]octane; antidepressants; anxiolytic agents |
| 06/08/2006 | US20060122215 Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-C]pyridine derivatives for the treatment of obesity |
| 06/08/2006 | US20060122207 Imidazol derivatives as Raf kinase inhibitors |
| 06/08/2006 | US20060122200 Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies |
| 06/08/2006 | US20060122198 Antiepileptic agent |
| 06/08/2006 | US20060122193 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 06/08/2006 | US20060122192 Chemical compounds |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060122172 Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
| 06/08/2006 | US20060122169 Succinoylamino benzodiazepines as inhibitors of Abeta protein production |
| 06/08/2006 | US20060122167 C6-and c9-substituted isoxazoline derivatives and their use as anti-depressants |
| 06/08/2006 | US20060122125 Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof |
| 06/08/2006 | US20060122124 Therapeutic agent |
| 06/08/2006 | US20060122110 Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system |
| 06/08/2006 | US20060122107 Method of modulating cellular activity and molecules for use therein |
| 06/08/2006 | US20060121529 CpG receptor (CpG-R) and methods relating thereto |
| 06/08/2006 | US20060121459 Receptors and membrane-associated proteins |
| 06/08/2006 | US20060121180 Using electrochemical solution containing metal compound and bioactive materials; contacting substrate |
| 06/08/2006 | US20060121132 TNF-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/08/2006 | US20060121056 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 06/08/2006 | US20060121034 Treatment for alzheimer's disease and related conditions |
| 06/08/2006 | US20060121015 Probiotic bifidobacterium strains |
| 06/08/2006 | US20060121013 Use of negative regulatory elements for the neurospecific expression of transgenes |
| 06/08/2006 | US20060121007 Generation of neuronal cells for use in the treatment of nervous system disorders; preparing nutrient broth contain nerve growth factor, inoculating with cells, producing neuronal precursor cells or glial precursor cells |
| 06/08/2006 | US20060120985 Novel ampiphilic derivatives of alpha-c-phenyl-n-tert-butyl nitrone |